SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-016763
Filing Date
2023-05-15
Accepted
2023-05-12 18:30:45
Documents
67
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 918789
2 ex3-1.htm EX-3.1 9594
3 ex31-1.htm EX-31.1 18773
4 ex31-2.htm EX-31.2 18415
5 ex32-1.htm EX-32.1 7219
6 ex32-2.htm EX-32.2 7147
  Complete submission text file 0001493152-23-016763.txt   4989858

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE aim-20230331.xsd EX-101.SCH 41020
8 XBRL CALCULATION FILE aim-20230331_cal.xml EX-101.CAL 48239
9 XBRL DEFINITION FILE aim-20230331_def.xml EX-101.DEF 178139
10 XBRL LABEL FILE aim-20230331_lab.xml EX-101.LAB 356581
11 XBRL PRESENTATION FILE aim-20230331_pre.xml EX-101.PRE 268516
61 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 659875
Mailing Address 2117 SW HIGHWAY 484 OCALA FL 32801
Business Address 2117 SW HIGHWAY 484 OCALA FL 32801 352-448-7797
AIM ImmunoTech Inc. (Filer) CIK: 0000946644 (see all company filings)

IRS No.: 520845822 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-27072 | Film No.: 23917633
SIC: 2836 Biological Products, (No Diagnostic Substances)